Publications by authors named "Richard Rae"

Claim this Profile
T
T cell margination: investigating the detour of T cells following forimtamig treatment in humanized mice.
Nils O'Brien, Joerg P J Mueller, Ann-Marie E Bröske, Jan Attig, Franz Osl, Richard Rae

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.
Jan Eckmann, Tanja Fauti, Marlene Biehl, Aintzane Zabaleta, Laura Blanco, Richard Rae

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Ugur Sahin, Petra Oehm, Evelyna Derhovanessian, Robert A Jabulowsky, Mathias Vormehr, Richard Rae

Nature· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance.
Nicole Bidmon, Sonja Kind, Marij J P Welters, Deborah Joseph-Pietras, Karoline Laske, Richard Rae

J Immunol Methods· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Ugur Sahin, Evelyna Derhovanessian, Matthias Miller, Björn-Philipp Kloke, Petra Simon, Richard Rae

Nature· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015.
Matthias Miller, Veronika Jahndel, Sarah Kutscher, Andrea Mahr, Richard Rae

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Lena M Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai, Richard Rae

Nature· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.
Björn-Philipp Kloke, Andrea Mahr, Robert A Jabulowsky, Sarah Kutscher, Richard Rae

Cancer Immunol Immunother· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of TCR-engineered T cells and their use to control the performance of T cell assays.
Nicole Bidmon, Sebastian Attig, Richard Rae, Helene Schröder, Tana A Omokoko

J Immunol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.
Björn-Philipp Kloke, Richard Rae, Andrea Mahr, Ute E Burkhardt, Pia Kvistborg

Cancer Immunol Immunother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
Björn-Philipp Kloke, Sarah Kutscher, Richard Rae, Pia Kvistborg, Cedrik M Britten

Cancer Immunol Immunother· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis